A Clinical Trial to Study the Efficacy, Safety, Tolerability and Pharmacokinetics of P2202 in Patients of Type 2 Diabetes

NCT01674348 · clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
48
Enrollment
INDUSTRY
Sponsor class

Stopped Due to non-recruitment, the study is being halted. There are no major safety or tolerability concerns in the study conducted so far.

Conditions

Interventions

Sponsor

Piramal Enterprises Limited